Available for acquisition is a rapidly growing specialty pharmacy platform operating through three integrated entities that provide specialty pharmacy, retail pharmacy, compounding services, and infusion therapies across a growing patient population in the Southcentral United States.
The Company has established a strong market position through long-standing referral relationships, favorable payer contracts, and a diversified therapeutic portfolio serving patients with complex and chronic care needs. The platform is supported by an experienced team of pharmacists, clinicians, technicians, and healthcare professionals dedicated to delivering exceptional patient outcomes and service excellence.
Key therapeutic categories include Hematology/Oncology, Pulmonary, Gastroenterology, HIV, Psychiatry, and Infusion therapies, providing diversified revenue streams and multiple opportunities for continued expansion. The Company benefits from established relationships with leading national pharmacy benefit managers and commercial payers, creating a scalable foundation for future growth.
For the trailing twelve months ended May 2026, the Company generated approximately $15.1 million in revenue and $2.3 million in adjusted EBITDA, representing a strong EBITDA margin profile. Revenue has increased from $10.6 million in 2023 to $15.1 million in 2026, demonstrating consistent organic growth and increasing market penetration.
The platform is further enhanced by a recently launched infusion entity, creating a compelling opportunity to accelerate growth, expand patient access, and increase participation in higher-acuity specialty therapies.
Investment Highlights
- Diversified specialty, retail, compounding, and infusion pharmacy platform
- Strong referral relationships and established market presence
- Attractive therapeutic mix concentrated in specialty disease states
- Proven revenue growth with expanding EBITDA
- Established contracts with leading national PBMs and commercial payers
- Experienced clinical and operational management team
- Newly launched infusion platform provides significant growth runway
- Highly scalable infrastructure suitable for strategic and private equity buyers
This opportunity represents an attractive acquisition for strategic acquirers seeking expanded specialty pharmacy capabilities, geographic market expansion, infusion growth, and enhanced patient access, as well as financial sponsors seeking a scalable healthcare platform with multiple avenues for value creation.
